1. Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations. Issue 2 (23rd January 2021) Authors: Hannan, Zain; Yu, Shun; Domchek, Susan; Mamtani, Ronac; Reiss, Kim A Journal: JNCI cancer spectrum Issue: Volume 5:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Harnessing the power of the immune system via blockade of PD-1 and PD-L1: a promising new anticancer strategy. (April 2014) Authors: Reiss, Kim A; Forde, Patrick M; Brahmer, Julie R Journal: Immunotherapy Issue: Volume 6:Number 4(2014:Apr.) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial. Issue 8 (August 2022) Authors: Reiss, Kim A; Mick, Rosemarie; Teitelbaum, Ursina; O'Hara, Mark; Schneider, Charles; Massa, Ryan; Karasic, Thomas; Tondon, Rashmi; Onyiah, Chioma; Gosselin, Mary Kate; Donze, Alyssa; Domchek, Susan M; Vonderheide, Robert H Journal: Lancet oncology Issue: Volume 23:Issue 8(2022) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The sadness connection. (February 2015) Authors: Reiss, Kim A Journal: International journal of psychiatry in medicine Issue: Volume 49:Number 2(2015) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗